openPR Logo
Press release

Driving Infection Control Market Growth in 2025: The Role of Rising Incidence Of Hospital-Acquired Infections Fuels Growth In The Infection Control Market

07-08-2025 12:55 PM CET | Health & Medicine

Press release from: The Business Research Company

Infection Control

Infection Control

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Infection Control Market Size Growth Forecast: What to Expect by 2025?
The market size of infection control has seen a robust growth in the past few years. It is projected to expand from $127.09 billion in 2024 to $134.79 billion in 2025, representing a compound annual growth rate (CAGR) of 6.1%. The historic period growth has been driven by factors such as healthcare-associated infections (HAIs), strict regulatory norms, increasing awareness about infectious diseases, global travel and globalization, as well as a rise in healthcare spending.

How Will the Infection Control Market Size Evolve and Grow by 2029?
The infection control market's scale is projected to witness significant expansion in the forthcoming years, expected to reach "$180.72 billion by 2029 while growing at a compound annual growth rate (CAGR) of 7.6%. Various factors such as emergency readiness for pandemics, the developing healthcare infrastructure, the increase in antimicrobial resistance, changing clearance regulations, and public health campaigns contribute to this growth during the projected period. Key trends encompassing this forecast period include the integration of technology in healthcare, novel technological developments in infection control products, advances in disinfection technology, increased focus on hand cleanliness, and quick sterilization methods.

View the full report here:
https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report

What Drivers Are Propelling the Growth of Infection Control Market Forward?
The surge in hospital-acquired infections is predicted to fuel the expansion of the infection control market. These infections, also known as healthcare-associated infections, are contracted in a hospital or another healthcare facility and consist of bloodstream infections associated with central-line catheter-associated urinary tract infections. The aim of infection control is to curtail these infections from spreading between individuals through top-tier services, sanitization, and sterilization services, thereby enhancing the infection control market. As an example, the World Health Organization, a health agency based in Switzerland, reported in May 2022 that more than 24% of patients globally suffered from healthcare-associated infections in 2022. Furthermore, the CDC, a US government agency, suggested that hospital-acquired infections in the US accounted for approximately 1.7 million infections and 99,000 deaths annually, with a further 32% of all healthcare-acquired infections occurring in the US by 2022. These figures are anticipated to grow moving forward. As such, the escalating rates of hospital-acquired infections are driving the infection control market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10061&type=smp

Which Emerging Trends Are Transforming the Infection Control Market in 2025?
The infection control market is evolving through user-centered design. In January 2024, US-based ICP Medical launched a redesigned website focused on accessibility and streamlined product browsing. The platform consolidates its infection prevention solutions like Rapid Refresh curtains and BootieButler shoe covers, while offering videos, samples, and detailed resources to support healthcare and government customers.

What Are the Key Segments in the Infection Control Market?
The infection control market covered in this report is segmented -

1) By Type: Disinfectors, Sterilization, Equipment, Consumables And Accessories, Services
2) By Distribution Channel: Direct Tender, Retail Sales, Third Party Distributors
3) By Application: Surgical Instruments, Endoscopes, Ultrasound Probes, Other Applications
4) By End User: Hospitals And Clinics, Medical Device Companies, Pharmaceutical Companies, Life Science Industry, Food Industry, Other End Users

Subsegments:
1) By Surface Disinfectors: Surface Disinfectors, Automated Disinfectors, Chemical Disinfectors
2) By Sterilization: Steam Sterilizers, Ethylene Oxide Sterilizers, Hydrogen Peroxide Sterilizers
3) By Equipment: Autoclaves, Washer-Disinfectors, Ultraviolet (UV) Sterilizers
4) By Consumables and Accessories: Sterilization Pouches, Disinfection Wipes, Cleaning Agents
5) By Services: Equipment Maintenance, Consulting Services, Training And Education Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10061&type=smp

Who Are the Key Players Shaping the Infection Control Market's Competitive Landscape?
Major companies operating in the infection control market include Belimed AG, 3M Company, Ecolab Inc., Advanced Sterilization Products Services Inc., Getinge AB, Matachana Group, Miele Group, Sotera Health Inc., Steris plc., Reckitt Benckiser Group plc., Pal International, Metrex Research LLC, Stryker Corporation, B. Braun Melsungen AG, Olympus Corporation, Fortive Corporation, Cantel Medical Corporation, MELAG Medizintechnik GmbH & Co. KG, The HUBSCRUB Company, Daniels Corporation International Pty. Ltd., Infection Control Consulting Services, Becton Dickinson and Company, Infection Control Results, Sterigenics International LLC, Bioquell Inc., Sterilmed Inc., Conmed Corporation, Johnson & Johnson

What Geographic Markets Are Powering Growth in the Infection Control Market?
North America was the largest region in the infection control market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global infection control market report during the forecast period. The regions covered in the infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10061

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Driving Infection Control Market Growth in 2025: The Role of Rising Incidence Of Hospital-Acquired Infections Fuels Growth In The Infection Control Market here

News-ID: 4095755 • Views:

More Releases from The Business Research Company

Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Forecast Report
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025? The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of
Sustained Release Excipients Market Advances With Product Innovation Industry Trends Gaining Momentum in the Global Sustained Release Excipients Market
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therapeutics Market Driving Market Acceleration in the RNA Targeting Small Molecules Therapeutics Industry, 2025
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025? In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as a Core Driver of the Remicade Biosimilar Market in 2025
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025? In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic

All 5 Releases


More Releases for Infection

Growing Hospital-Acquired Infection Rates Boost Demand For Infection Prevention …
The Infection Prevention Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Infection Prevention Market? In the past few years, there has been a consistent increase in the size of the infection prevention market. It is predicted that this market
Prominent Infection Prevention Market Trend for 2025: Strategic Staffing Innovat …
What Are the Projected Growth and Market Size Trends for the Infection Prevention Market? The infection prevention market is expected to grow from $43.4 billion in 2024 to $45.01 billion in 2025, reflecting a CAGR of 3.7%. Growth drivers include increasing awareness of healthcare-associated infections (HAIs), stringent regulatory guidelines, technological advancements, and globalization. The Infection Prevention market is expected to grow to $52.2 billion by 2029 at a CAGR of 3.8%, driven
Yeast Infection Treatment Market Report 2024 - Yeast Infection Treatment Market …
"The Business Research Company recently released a comprehensive report on the Global Yeast Infection Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The yeast infection
Combating Infection: Nontuberculous Mycobacterial Infection Market Analysis 2024 …
The nontuberculous mycobacterial infection market size has grown strongly in recent years. It will grow from $13.43 billion in 2023 to $14.25 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to improved diagnostics, aging population, cystic fibrosis awareness, immunosuppressive medications. The nontuberculous mycobacterial infection market size is expected to see strong growth in the next few
Infection Surveillance Solutions Market: Empowering Infection Prevention | BD, B …
Allied Market Research analysts have recently introduced a new research study titled "Infection Surveillance Solutions Market- Global Outlook and Forecast 2023-2030." The report offers detailed insights and highlights key players in the industry, including Atlas Medical Software, Becton, Dickinson and Company, Baxter International, GOJO Industries, Deb Group, RL Solutions, HyGreen, Wolters Kluwer, Premier, and Truven Health Analytics. This comprehensive study provides in-depth and clear analysis, encompassing market definitions, classifications, manufacturing
Infection Prevention & Control Market 2026: Product Overview and Scope of Infect …
Infection Prevention & Control Market Research Report and Forecast to 2019-2026 Report provide an extensive research on the fast-evolving Infection Prevention & Control Market. It also gives competitive landscape of the leading companies with regional and Global analysis of the market till 2026. The report mainly studies the size, recent trends and development status of the Infection Prevention & Control market, as well as investment opportunities, government policy, market dynamics (drivers,